Mergers & Acquisitions ·
Waldencast reports $26.1M H1 revenue, a 57% drop, and plans to delist from Nasdaq
WALDWaldencast plc
Waldencast plc reported H1 2026 results showing a 57.1% revenue decline to $26.1 million and a net loss of $94.9 million from continuing operations, driven by a $52.3 million goodwill impairment at Milk Makeup. The company completed the sale of its Obagi Medical business to Bridgepoint on July 30, 2026, receiving $149.9 million in net cash proceeds which were used to fully repay $178.4 million in debt. Waldencast announced plans to voluntarily delist from Nasdaq and rebrand as Milk Makeup plc following shareholder approval. The beauty brand operates clean, prestige cosmetics primarily through retail partners like Sephora.